Demo Sign up Log In

Xeris Biopharma Holdings Inc (XERS)

EV/EBITDA

128.64×

TTM · Retrieved: Oct 21, 2026

XERS EV/EBITDA

Current (TTM)128.64×retrievedOct 21, 2026

Current (TTM)128.64×retrievedOct 21, 2026

XERS Quarterly EV/EBITDA (-15.88× → -73.36×)

Latest values, visible window

High-resolution chart · PNG

XERS ev/ebitda history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc EV/EBITDA — Quarterly
Period ending	EV/EBITDA
Jun 30, 2026	-73.3602×
Mar 31, 2026	74.1899×
Dec 31, 2025	87.0333×
Sep 30, 2025	125.6898×
Jun 30, 2025	107.7877×
Mar 31, 2025	852.8006×
Dec 31, 2024	123.231×
Sep 30, 2024	-78.0625×
Jun 30, 2024	-170.2071×
Mar 31, 2024	-60.1287×
Dec 31, 2023	-145.2181×
Sep 30, 2023	-188.8038×
Jun 30, 2023	-50.6911×
Mar 31, 2023	-49.8824×
Dec 31, 2022	-47.6015×
Sep 30, 2022	-17.6362×
Jun 30, 2022	-12.5634×
Mar 31, 2022	-13.7797×
Dec 31, 2021	-7.8476×
Sep 30, 2021	-8.0015×
Jun 30, 2021	-11.5745×
Mar 31, 2021	-18.2328×
Dec 31, 2020	-18.5891×
Sep 30, 2020	-26.7248×
Jun 30, 2020	-4.9896×
Mar 31, 2020	-3.0397×
Dec 31, 2019	-7.2447×
Sep 30, 2019	-9.2035×
Jun 30, 2019	-8.3806×
Mar 31, 2019	-8.2615×
Dec 31, 2018	-17.6833×
Sep 30, 2018	-6.906×
Jun 30, 2018	2.9202×
Mar 31, 2018	-0.3269×
Dec 31, 2017	0.033×
Sep 30, 2017	0×
Jun 30, 2017	0×
Mar 31, 2017	-15.8827×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.